Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
mastodon.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
The original server operated by the Mastodon gGmbH non-profit

Administered by:

Server stats:

353K
active users

mastodon.social: AboutStatusProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.4.0-nightly.2025-03-25

#chronicconditions

0 posts0 participants0 posts today
Public
LeliBug Vaeda

BLOG | Time Has No Meaning... Neither Does Life

Everything is too much and too little...

delphinemusic.wordpress.com/20 , , , , , , , , , , , , , , , , , , ,

DelphineMusic | LeliBug Phoenix · Time Has No Meaning… Neither Does LifeTime slips by and means Nothing. Days, Weeks, Months and Years just… vanish… into a dim mist of vague dreamlike memories of barely-there Things-That-Happened…I exist barely in any…
Continued thread
Public
Christophe Veltsos

Direct link to the research mentioned in the thread above: Medical Risk Classification For Severe COVID-19 Based On Chronic Medical Conditions: A Comparative Analysis | medRxiv www.medrxiv.org/content/10.1... #Covid #Classification #ChronicConditions

Medical Risk Classification Fo...

medRxiv · Medical Risk Classification For Severe COVID-19 Based On Chronic Medical Conditions: A Comparative AnalysisBackground: The European Centre for Disease Prevention and Control (ECDC) provides listings of medical conditions conferring high- or moderate-risk for severe COVID-19. In addition, individual European countries developed their own risk classifications for severe COVID-19 to select individuals recommended for annual COVID-19 vaccination. We assessed the discordance between the European and respective national medical risk classifications in assigning children and adults to risk groups for developing severe COVID-19 in populations of the Netherlands and Norway. Methods: This multi-country, healthcare data-linkage study covered 17.4 million inhabitants of the Netherlands and 5.6 million inhabitants of Norway by 1 January 2020. Medical conditions were defined based on ICD-10 hospital discharge codes in the European and Dutch classifications, and on ICD-10 and ICPC-2 primary care codes in the Norwegian classification. Subjects were classified as high-, moderate-, or low-risk. Discordance was calculated as the proportion of the population with a different risk status in the respective national compared to the European classification. Findings: The overall discordance between European and national risk classification was 12.0% in the Dutch and 13.8% in the Norwegian population. The European classification assigns more individuals to high-risk (9.0% and 9.2% of the Dutch and Norwegian populations, respectively) than the national classifications (1.5% and 3.0%, respectively). National classifications define more individuals as moderate-risk (11.3% and 12.7%, respectively) than the European classification (1.0% and 1.3%, respectively). Classification discordances most frequently involved subjects with cardiovascular disease, lung disease, and diabetes mellitus. Interpretation: The European classification defines a substantially larger percentage of the population as high-risk for severe COVID-19 than the national classifications. This may have implications for post-pandemic vaccination programs. Further research should assess to what extent the medical conditions responsible for the classification discordances determine the risk of developing severe COVID-19. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement GR, IW, AdB, and OB were supported by the ZonMw project (10430362220002). GR was supported by Fundacao para a Ciencia e a Tecnologia project 2022.01448.PTDC, DOI 10.54499/2022.01448.PTDC. GR, IW, AL, and PB were supported by the VERDI project (101045989), funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. IW was supported by the scholarship program iAPOGEE (International Alliance for PharmacoGenetic Epidemiology Excellence) at the University of Oslo, Norway. Data acquisition of the Norwegian data in this study was funded by HNs EU-COVID-19 project, funded by the Norwegian Research Councils COVID-19 Emergency Call (project no. 31270). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes The aggregated tables of counts generated and analyzed in this study are publicly available at https://github.com/IWesterhof/COVID-19-risk-classifications. <https://github.com/IWesterhof/COVID-19-risk-classifications>
Public
Maitreya Levanchild

🙌🏽🥳 Ahhh, the elation of simply not feeling *absolutely terrible*!

I dedicate this special moment (passing as it might be 😝) to folks out there also with #ChronicConditions (1 or 10+ of them 😂) 🤙🏽

You rock, *even if / when you don't feel like it*! 🤘🏽

#wellbeing #wellness #ChronicIllness #disability #disabilities #ChronicPain #Migraine #POTS #MECFS #CFS #MyalgicEncephalomyelitis #EhlersDanlosSyndrome #Hypermobility #Dysautonomia #health #MentalHealth
@chronicillness @mecfs

Public
Corrosive Dream

"Investing US$1 billion every year for the next ten years into #longCOVID #research could improve the lives of millions and save trillions in economic costs."

"Infection-associated #chronicConditions, in which infections cause debilitating symptoms that persist for months, years or indefinitely, are under-studied."

"It could lessen #morbidity and #disability for generations to come."

#PostCovid #Covid #Corona #Covid19 #MECFS

nature.com/articles/d41586-023

www.nature.comLong COVID research risks losing momentum – we need a moonshotInvesting US$1 billion every year for the next ten years into long COVID research could improve the lives of millions and save trillions in economic costs.
ExploreLive feeds
About